SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostra Terra Regulatory News (NTOG)

  • There is currently no data for NTOG

GM Statement

1 Jul 2019 16:09

RNS Number : 0930E
Nostra Terra Oil & Gas Company PLC
01 July 2019
 

1 July 2019

 

Nostra Terra Oil and Gas Company plc

("Nostra Terra" or the "Company")

 

Notice of General Meeting

 

Nostra Terra (AIM:NTOG), the oil and gas exploration and production company with a portfolio of assets in the USA and Egypt, announces that it has posted a notice to shareholders convening a General Meeting (the "GM") to be held at 11.00 am on 26 July 2019 at the offices of Jeffreys Henry LLP at Finsgate, 5-7 Cranwood Street, London EC1V 9EE in order to approve the 2018 Annual Report & Accounts. 

As previously announced on 5 June 2019, the resolution relating to the approval of the 2018 Annual Report & Accounts was adjourned at the Nostra Terra's core asset is a 100% working interest in the Mesquite asset located in the prolific Permian Basin in West Texas. The Mesquite asset covers 1,984 net acres with estimated proven recoverable reserves of 2.4mmbbls.

 

Nostra Terra also has interests in three additional Permian Basin properties in close proximity to Mesquite and currently producing from two wells. The first well reach pay-out in less than one year.

 

Furthermore, Nostra Terra has a 100% working interest in the well-established East Texas region (Pine Mills oil field with current production of approximately 130bopd), USA and a 50% working interest in the East Ghazalat Concession, Egypt. For further information, please visit our website: www.ntog.co.ukCompany's AGM held on 28 June 2019.

The notice of GM is also available on the Company's website.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, visit www.ntog.co.uk or contact:

 

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

 

+1 480 993 8933

Strand Hanson Limited

(Nominated & Financial Adviser & Joint Broker)

+44 (0) 20 7409 3494

Rory Murphy / Ritchie Balmer / Jack Botros

Shard Capital Stockbrokers (Joint Broker)

+44 (0) 207 186 9952

Damon Heath / Erik Woolgar

 

Lionsgate Communications (Public Relations)

+44 (0) 203 697 1209

Jonathan Charles

 

About Nostra Terra

Nostra Terra's core asset is a 100% working interest in the Mesquite asset located in the prolific Permian Basin in West Texas. The Mesquite asset covers 1,984 net acres with estimated proven recoverable reserves of 2.4mmbbls.

Nostra Terra also has interests in three additional Permian Basin properties in close proximity to Mesquite and currently producing from two wells. The first well reach pay-out in less than one year.

Furthermore, Nostra Terra has a 100% working interest in the well-established East Texas region (Pine Mills oil field with current production of approximately 130bopd), USA and a 50% working interest in the East Ghazalat Concession, Egypt. For further information, please visit our website: www.ntog.co.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
GMSUARVRKVABRAR
Date   Source Headline
26th Jun 20257:00 amRNSChange of Name
20th Jun 202510:40 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNS-REngage Investor Presentation
23rd May 20257:00 amRNS2024 Audited Annual Results & Notice of AGM
3rd Apr 20257:00 amRNSPartner Approval for Fouke 3 Well
17th Mar 20257:00 amRNS-REngage Investor Presentation
11th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSCompletion of £500,000 Fundraise
24th Feb 20257:00 amRNSProduction and Operations Update
11th Feb 202512:57 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNS3-Year Renewal of Senior Lending Facility
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 202512:29 pmRNSHolding(s) in Company
21st Jan 20257:05 amRNSIncreased Holdings in the Company
21st Jan 20257:00 amRNSProduction and Operations Update
2nd Jan 20257:00 amRNSBoard Change
27th Dec 20244:35 pmRNSHolding(s) in Company
27th Dec 20247:00 amRNSHolding(s) in Company
28th Nov 202412:15 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFundraise to increase production & cash flow
12th Nov 20244:48 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSProduction and Operations Update
20th Sep 202411:50 amRNSShare Issuance
20th Sep 20247:00 amRNSShare Issuance
19th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
6th Sep 20247:00 amRNSChange of Nominated Adviser
29th Aug 202412:30 pmRNSHolding(s) in Company
27th Aug 202412:41 pmRNSHolding(s) in Company
22nd Aug 20244:54 pmRNSHolding(s) in Company
20th Aug 202412:15 pmRNSHolding(s) in Company
19th Aug 20243:52 pmRNSHolding(s) in Company
16th Aug 20244:45 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20244:56 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 202411:52 amRNSHolding(s) in Company
2nd Aug 20244:28 pmRNSDirector Increases Participation in Fundraise
29th Jul 20247:00 amRNS£450,000 Fundraise aimed at increasing production
17th Jul 202411:08 amRNSAdvisor Change
17th Jul 202410:13 amRNSResult of Meeting
1st Jul 20245:00 pmRNSCorporate Update & Notice of General Meeting
27th Jun 20242:46 pmRNSResult of AGM
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
13th Jun 20247:00 amRNSProposed Appointment of Non-Executive Director
31st May 20247:00 amRNSFinal Results
20th May 20248:01 amRNSBoard Changes
22nd Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20249:23 amRNSHolding(s) in Company
30th Jan 20249:37 amRNSHolding(s) in Company
30th Jan 20249:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.